Loading…
KALA BIO, Inc. is projected to decline to $2.17 by 2027, a -7% move from its current price of $2.33. KALA is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $2.16 | $2.33 | $2.51 | -0.06% |
| May 30 | $2.09 | $2.33 | $2.59 | -0.13% |
| May 31 | $2.04 | $2.33 | $2.65 | -0.19% |
| Jun 1 | $2.00 | $2.32 | $2.70 | -0.25% |
| Jun 2 | $1.96 | $2.32 | $2.75 | -0.32% |
| Jun 3 | $1.93 | $2.32 | $2.79 | -0.38% |
| Jun 4 | $1.90 | $2.32 | $2.83 | -0.44% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $1.90 | $2.32 | $2.83 | -0.44% |
| Week 2 | $1.74 | $2.31 | $3.07 | -0.88% |
| Week 3 | $1.62 | $2.30 | $3.25 | -1.32% |
| Week 4 | $1.53 | $2.29 | $3.42 | -1.76% |
| Week 5 | $1.46 | $2.28 | $3.57 | -2.19% |
| Week 6 | $1.39 | $2.27 | $3.71 | -2.62% |
| Week 7 | $1.33 | $2.26 | $3.84 | -3.05% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
KALA BIO, Inc. is a biopharmaceutical company that engages in the development of an on-premises artificial intelligence infrastructure platform for biotechnology research applications in the United States.
The company develops Researgency, an agentic AI research platform for private enterprise AI deployment, and its platform intends to utilize the KPI-012 clinical development dataset as a proof-of-concept validation environment, as well as the mesenchymal stem cell secretome (MSC-S) and persistent corneal epithelial defects (PCED) research for agentic workflows on trial data.
The company was formerly known as Kala Pharmaceuticals, Inc. and changed its name to KALA BIO, Inc. in August 2023. KALA BIO, Inc. was incorporated in 2009 and is headquartered in Arlington, Massachusetts.
KALA BIO, Inc. has a current price of $2.43 and a market capitalization of $45.17M, with a rank of 4640.
The forecast trajectory suggests long-term upside, with 2026 at a mean of $2.43 and a 2050 max of $19.46, corresponding to a potential total return of 248.1% in the far horizon.
This outlook shows a path of variable year-to-year performance, including years with flat or modest gains and years with stronger upside, as captured in the year-by-year forecast.
A major floor 6.9% below — a decisive break under it would weaken the trend.
The nearest floor, 6.9% below — buyers have tended to step in here.
The nearest ceiling, 329.2% above — a clean break opens room to run.
A major ceiling 1348.5% above — clearing it would confirm fresh momentum.
Key KALA support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of KALA market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $2.44 | Sell | $2.43 | Sell |
| MA 10 | $2.65 | Sell | $2.82 | Sell |
| MA 20 | $3.73 | Sell | $3.91 | Sell |
| MA 50 | $7.21 | Sell | $8.59 | Sell |
| MA 100 | $15.32 | Sell | $30.85 | Sell |
| MA 200 | $135.68 | Sell | $92.99 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 21.95 | Buy |
| Stoch RSI (14) | 52.77 | Neutral |
| CCI (20) | -81.87 | Neutral |
| Williams %R (14) | -91.92 | Info |
| MACD (12,26,9) | 0.13 | Buy |
| ROC (12) | -41.01 | Sell |
| Bollinger %B (20,2) | 0.22 | Neutral |
| Stochastic %K (14) | 8.08 | Buy |
| TRIX (15) | -3.60 | Sell |
| Awesome (5,34) | -3.45 | Sell |
| Ultimate (7,14,28) | 17.89 | Buy |
| Momentum (10) | -0.79 | Sell |
| Aroon Osc (25) | -96.00 | Sell |
| Hull MA (9) | 2.23 | Buy |
| ADX (14) | 50.09 | Sell |
| ATR (14) | 0.33 | Info |
Market sentiment is NEUTRAL, and the RSI14 is 20.
The stock’s 50-day simple moving average (SMA50) is $7.67 and the 200-day simple moving average (SMA200) is $139.29, indicating a wide gap between near-term momentum and longer-term trend levels.
Support is at $2.43 and resistance at $11.30. The 30-day price range spans from $1.48 to $4.00, and annualized volatility is 100%.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $2.17 | $2.33 | $2.85 | 0% | Neutral | |
| $1.56 | $2.17 | $3.27 | -7% | Neutral | |
| $1.41 | $2.07 | $3.31 | -11% | Neutral | |
| $1.89 | $2.93 | $4.91 | +26% | Bullish | |
| $2.09 | $3.40 | $5.93 | +46% | Bullish | |
| $1.59 | $2.69 | $4.86 | +16% | Neutral | |
| $1.57 | $2.78 | $5.16 | +19% | Neutral | |
| $1.51 | $2.79 | $5.34 | +20% | Neutral | |
| $1.25 | $2.40 | $4.69 | +3% | Neutral | |
| $1.62 | $3.24 | $6.49 | +39% | Bullish | |
| $1.49 | $3.31 | $7.29 | +42% | Bullish | |
| $3.63 | $8.07 | $18.55 | +246% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $2.17 | $2.33 | $2.78 | +0.00% |
| June 2026 | $1.97 | $2.36 | $2.94 | +1.50% |
| July 2026 | $1.80 | $2.20 | $2.80 | -7.00% |
| August 2026 | $1.74 | $2.16 | $2.80 | -1.98% |
| September 2026 | $1.83 | $2.29 | $3.02 | +6.31% |
| October 2026 | $1.79 | $2.25 | $3.02 | -1.63% |
| November 2026 | $1.63 | $2.08 | $2.82 | -7.78% |
| December 2026 | $1.62 | $2.08 | $2.85 | +0.04% |
Click any year to see its month-by-month KALA forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, KALA could reach as high as $2.85, with a base case around $2.33 and support toward $2.17 — roughly 0% from $2.33. Price action looks broadly range-bound.
Expect KALA to range from $1.56 to $3.27 through 2027. The $2.17 average target implies a -7% move from current prices. That is -7% versus the projected 2026 average. A consolidation phase looks the most probable path here.
The KALA price prediction for 2028 points to an average of $2.07 (low $1.41, high $3.31) — a potential decline of -11% on today's $2.33. Price action looks broadly range-bound.
In 2029, KALA is projected to trade between $1.89 and $4.91, averaging $2.93 — a potential gain of +26% from today's $2.33. That is up +41% on the projected 2028 average. Buyers look set to stay in control over this stretch.
KALA BIO, Inc.'s 2030 outlook centres on $3.40, within a $2.09 to $5.93 range. That is up +16% on the projected 2029 average. That marks a +46% change versus current levels. Momentum favours further upside here.
By 2031, KALA could reach as high as $4.86, with a base case around $2.69 and support toward $1.59 — roughly +16% from $2.33. A consolidation phase looks the most probable path here.
Expect KALA to range from $1.57 to $5.16 through 2032. The $2.78 average target implies a +19% move from current prices. That is up +3% on the projected 2031 average. Price action looks broadly range-bound.
The KALA price prediction for 2033 points to an average of $2.79 (low $1.51, high $5.34) — a potential gain of +20% on today's $2.33. A consolidation phase looks the most probable path here.
In 2034, KALA is projected to trade between $1.25 and $4.69, averaging $2.40 — a potential gain of +3% from today's $2.33. That is -14% versus the projected 2033 average. Price action looks broadly range-bound.
KALA BIO, Inc.'s 2035 outlook centres on $3.24, within a $1.62 to $6.49 range. That is up +35% on the projected 2034 average. That marks a +39% change versus current levels. Buyers look set to stay in control over this stretch.
By 2040, KALA could reach as high as $7.29, with a base case around $3.31 and support toward $1.49 — roughly +42% from $2.33. Momentum favours further upside here.
Expect KALA to range from $3.63 to $18.55 through 2050. The $8.07 average target implies a +246% move from current prices. That is up +143% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in KALA today (≈ 429.184549 KALA) could be worth
$3,461.88
+$2,461.88 (+246%) by 2050 · US Dollar
Based on the average projected KALA price of $8.07 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in KALAwould be worth at today's price.
$1,000 invested in KALA on May 27, 2025 (≈ 4.926108 KALA) would be worth
$11.48
-$988.52 (-98.9%) today · 0.01× · US Dollar
Based on a KALA entry price of $203 vs. today's $2.33.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $2.65 | $879.25 | -12.1% |
| 1 month ago | $5.95 | $391.6 | -60.8% |
| 3 months ago | $19 | $122.63 | -87.7% |
| 6 months ago | $48.3 | $48.24 | -95.2% |
| 1 year ago | $203 | $11.48 | -98.9% |
| All time (5.0y) ago | $13,600 | $0.17 | -100.0% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our KALA forecast.
Our base-case forecast reaches $4.70 around 2050.
Implied market cap at $4.70: $87.37M
Over the multi-year horizon, the forecast shows a sequence of movements with notable upside in several years. The 2026 average is $2.43 with a 0% ROI and NEUTRAL sentiment; the 2029 average is $3.09 with a 27.1% ROI and a BULLISH tone, followed by 2030 averaging $3.53 with a 45.2% ROI and BULLISH sentiment.
Beyond 2030, the forecast continues with 2032 at an average of $2.93 (20.5% ROI, BULLISH), 2035 at $3.42 (40.7% ROI, BULLISH), and 2040 at $3.44 (41.6% ROI, BULLISH). By 2050, the average is $8.46 with a 248.1% ROI and BULLISH sentiment, while the max reaches $19.46.
These figures imply substantial upside potential in later years, but also highlight period-by-period variability and risk, including years with negative or neutral returns in the forecast path.
Tap a question to reveal the answer.
Avg $3.53, min $2.17, max $6.16, ROI 45.2%, sentiment BULLISH.
The forecast shows mixed results across years, with negative ROI in 2027 (-7.6%) and 2028 (-10.7%), but meaningful upside in 2029 (27.1%), 2030 (45.2%), and 2050 (248.1%). The overall picture includes both risk and potential upside.
The 30-day resistance is $11.30, but the max forecasts reach $19.46 in 2050, so prices above $11.30 are possible by 2050.
Current price is $2.43 and market cap is $45.17M.
Min $2.43, avg $2.43, max $3.00; ROI 0; sentiment NEUTRAL.
KALA BIO, Inc. Community Discussion
0Share your KALA BIO, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.